VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.8 Million EUR | 129.12% |
| 2022 | -18.34 Million EUR | -1791.8% |
| 2021 | 949 Thousand EUR | -82.2% |
| 2020 | 5 Million EUR | -6.81% |
| 2019 | 5.47 Million EUR | 22.77% |
| 2018 | 4.12 Million EUR | 184.5% |
| 2017 | 1.89 Million EUR | -26.89% |
| 2016 | 2.36 Million EUR | -42.07% |
| 2015 | 136 Thousand EUR | 52.64% |
| 2014 | 2.22 Million EUR | -3.63% |
| 2013 | 2.65 Million EUR | 494.88% |
| 2012 | 414 Thousand EUR | -38.83% |
| 2011 | 638 Thousand EUR | -61.27% |
| 2010 | 1.89 Million EUR | 35.36% |
| 2009 | 1.4 Million EUR | 203.17% |
| 2008 | -1.7 Million EUR | -1300.88% |
| 2007 | 113 Thousand EUR | -98.76% |
| 2006 | 988 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 674 Thousand EUR | 5.75% |
| 2024 Q1 | 1.19 Million EUR | 59.7% |
| 2023 Q3 | 2.96 Million EUR | 85.13% |
| 2023 Q4 | 1.43 Million EUR | -51.62% |
| 2023 Q1 | 679 Thousand EUR | 103.9% |
| 2023 FY | - EUR | 129.12% |
| 2023 Q2 | 1.6 Million EUR | 135.64% |
| 2022 Q2 | -1.15 Million EUR | -24.49% |
| 2022 FY | - EUR | -1791.8% |
| 2022 Q3 | 1.8 Million EUR | 255.74% |
| 2022 Q4 | -17.41 Million EUR | -1064.54% |
| 2022 Q1 | -931 Thousand EUR | 65.87% |
| 2021 Q2 | 974 Thousand EUR | -8.29% |
| 2021 Q4 | -2.72 Million EUR | -262.67% |
| 2021 Q3 | 1.67 Million EUR | 72.18% |
| 2021 FY | - EUR | -82.2% |
| 2021 Q1 | 1.06 Million EUR | 7.71% |
| 2020 Q1 | 1.17 Million EUR | -3.7% |
| 2020 Q4 | 986 Thousand EUR | -44.42% |
| 2020 Q2 | 1.48 Million EUR | 27.09% |
| 2020 FY | - EUR | -6.81% |
| 2020 Q3 | 1.77 Million EUR | 19.3% |
| 2019 Q1 | 1.29 Million EUR | 68.75% |
| 2019 FY | - EUR | 22.77% |
| 2019 Q2 | 1.52 Million EUR | 17.28% |
| 2019 Q3 | 1.76 Million EUR | 15.79% |
| 2019 Q4 | 1.21 Million EUR | -30.97% |
| 2018 Q2 | 953 Thousand EUR | -11.6% |
| 2018 Q3 | 1.29 Million EUR | 35.36% |
| 2018 Q4 | 768 Thousand EUR | -40.47% |
| 2018 FY | - EUR | 184.5% |
| 2018 Q1 | 1.07 Million EUR | 11.83% |
| 2017 Q3 | 1.08 Million EUR | 200.09% |
| 2017 Q1 | 723 Thousand EUR | 26.84% |
| 2017 FY | - EUR | -26.89% |
| 2017 Q4 | 964 Thousand EUR | -10.91% |
| 2017 Q2 | -1.08 Million EUR | -249.52% |
| 2016 FY | - EUR | -42.07% |
| 2016 Q3 | 763 Thousand EUR | 37.48% |
| 2016 Q4 | 570 Thousand EUR | -25.29% |
| 2016 Q2 | 555 Thousand EUR | 51.64% |
| 2016 Q1 | 366 Thousand EUR | -82.58% |
| 2015 Q4 | 2.1 Million EUR | 231.39% |
| 2015 Q3 | 634 Thousand EUR | 22.39% |
| 2015 Q1 | 660 Thousand EUR | -39.45% |
| 2015 FY | - EUR | 52.64% |
| 2015 Q2 | 518 Thousand EUR | -21.52% |
| 2014 Q1 | 638 Thousand EUR | -40.49% |
| 2014 Q2 | 238 Thousand EUR | -62.7% |
| 2014 Q3 | 846 Thousand EUR | 255.46% |
| 2014 Q4 | 1.09 Million EUR | 28.84% |
| 2014 FY | - EUR | -3.63% |
| 2013 Q4 | 1.07 Million EUR | 67.76% |
| 2013 Q3 | 639 Thousand EUR | 13.7% |
| 2013 Q2 | 562 Thousand EUR | 41.21% |
| 2013 Q1 | 398 Thousand EUR | 107.29% |
| 2013 FY | - EUR | 494.88% |
| 2012 Q2 | 58 Thousand EUR | 70.59% |
| 2012 FY | - EUR | -38.83% |
| 2012 Q3 | 165 Thousand EUR | 184.48% |
| 2012 Q4 | 192 Thousand EUR | 16.36% |
| 2012 Q1 | 34 Thousand EUR | -89.34% |
| 2011 Q2 | 32 Thousand EUR | 126.89% |
| 2011 Q3 | 502 Thousand EUR | 1468.75% |
| 2011 FY | - EUR | -61.27% |
| 2011 Q4 | 319 Thousand EUR | -36.45% |
| 2011 Q1 | -119 Thousand EUR | -117.32% |
| 2010 Q2 | 398 Thousand EUR | 5.85% |
| 2010 Q1 | 376 Thousand EUR | -8.07% |
| 2010 FY | - EUR | 35.36% |
| 2010 Q4 | 687 Thousand EUR | 58.29% |
| 2010 Q3 | 434 Thousand EUR | 9.05% |
| 2009 Q1 | -22 Thousand EUR | 0.0% |
| 2009 Q3 | 636 Thousand EUR | 197.2% |
| 2009 FY | - EUR | 203.17% |
| 2009 Q4 | 409 Thousand EUR | -35.69% |
| 2009 Q2 | 214 Thousand EUR | 1072.73% |
| 2008 Q2 | -784 Thousand EUR | 0.0% |
| 2008 FY | - EUR | -1300.88% |
| 2007 FY | - EUR | -98.76% |
| 2006 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 2.93 Billion EUR | 99.802% |
| Fresenius SE & Co. KGaA | 2.73 Billion EUR | 99.788% |
| LIMES Schlosskliniken AG | 854.98 Thousand EUR | -579.079% |
| M1 Kliniken AG | 21.79 Million EUR | 73.358% |
| Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | -23.139% |
| MEDICLIN Aktiengesellschaft | 101.26 Million EUR | 94.266% |
| RHÖN-KLINIKUM Aktiengesellschaft | 116.58 Million EUR | 95.02% |